<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/cost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/cost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2008-08-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2008-08-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/cost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s/"},"url":"https://clinicaltree.github.io/posts/cost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s/"}</script><title>Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Cost-effectiveness of Treatment of Unruptured Intracranial Aneurysms in Patients with a History of Subarachnoid Hemorrhage</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1220202000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Aug 31, 2008 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Hidemasa Takao MD</a> </em>, <em> <a href="">Takeshi Nojo MD MPH</a> </em>, <em> <a href="">Kuni Ohtomo MD DMSc</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2505 words"> <em>13 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The study goal was to evaluate the cost-effectiveness of surgery and endovascular treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage from a previous aneurysm, incorporating the results of the prospective International Study of Unruptured Intracranial Aneurysms.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Using a Markov model, we performed a decision and cost-effectiveness analysis comparing surgery or endovascular treatment with no treatment. Twelve clinical scenarios were defined based on aneurysm size and location. Probabilistic sensitivity analyses were performed for 50- and 40-year-old cohorts. Treatment was considered to be cost-effective at an incremental cost-effectiveness ratio less than $100,000 per quality-adjusted life-year.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In 50-year-old patients, no treatment was the most cost-effective strategy for aneurysms located in the cavernous carotid artery. For aneurysms less than 7 mm located in the anterior circulation, no treatment was the most cost-effective strategy. Endovascular treatment was the most cost-effective option for 7- to 24-mm aneurysms, whereas surgery was the most cost-effective option for aneurysms of 25 mm or larger. For aneurysms less than 7 mm and located in the posterior circulation, endovascular treatment was the most cost-effective option, whereas surgery was the most cost-effective option for 7- to 12-mm aneurysms. No treatment was the most cost-effective strategy for aneurysms of 13 mm or larger.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>For 50-year-old patients with a history of aneurysmal subarachnoid hemorrhage, treatment of unruptured aneurysms that are located in the cavernous carotid artery, or small (&lt;7 mm) and located in the anterior circulation, or large (≥13 mm) and located in the posterior circulation is ineffective or not cost-effective.</p><p>Most cases of subarachnoid hemorrhage (SAH) are caused by ruptured intracranial aneurysms. Unruptured intracranial aneurysms are relatively common, affecting up to 2% to 5% of the population ( ). The management of unruptured intracranial aneurysms depends on the natural history of these lesions and on morbidity and mortality rates associated with their repair. There is still controversy about the management of unruptured intracranial aneurysms ( ). In 2003, the International Study of Unruptured Intracranial Aneurysms (ISUIA) investigators reported prospective data on the natural history and treatment outcomes of unruptured intracranial aneurysms ( ). Aneurysm rupture rates varied depending on aneurysm size and location, and treatment outcomes depended on patient age and aneurysm size and location ( ). Patients with a history of SAH from a previous aneurysm had a higher risk of aneurysm rupture than patients without a history of SAH ( ). In addition, patients with a history of aneurysmal SAH have a higher mortality rate than the general population even after successful treatment of ruptured aneurysms ( ). Previous decision and cost-effectiveness analyses were based on earlier estimates of rupture and complication rates and did not consider these factors in their models ( ). Most analyses evaluated the effectiveness or cost-effectiveness of treatment of unruptured intracranial aneurysms only in patients without a history of SAH ( ). The purpose of our study was to evaluate the cost-effectiveness of surgery and endovascular treatment of unruptured intracranial aneurysms in patients with a history of SAH from a previous aneurysm, incorporating the results of the prospective ISUIA ( ).</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-design"><span class="mr-2">Study Design</span><a href="#study-design" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We performed a decision and cost-effectiveness analysis from the societal perspective in which we simulated the clinical paths and health states that patients with a history of SAH from a previous aneurysm would traverse having undergone or not undergone surgery or endovascular treatment for unruptured intracranial aneurysms ( ). Although standard practice in cost-effectiveness analysis is to compare each treatment to the next best option, we chose to compare both treatments to no treatment as our aim in this study was to decide which unruptured intracranial aneurysms should be treated. We assumed that a previous ruptured aneurysm was completely obliterated after the first SAH and that the patient was well (not disabled). Patients with a history of SAH from a previous aneurysm have a higher risk of aneurysm rupture than patients without a history of SAH ( ). Aneurysm rupture rates vary depending on aneurysm size and location ( ). To account for variable aneurysm characteristics, we modeled 12 different clinical scenarios.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="the-markov-model"><span class="mr-2">The Markov Model</span><a href="#the-markov-model" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Probabilities</p><p>Baseline Range Source Aneurysm rupture rates (per y), % ISUIA, 2003 ( ) Cavernous carotid artery aneurysms &lt;7 mm 0 — 7–12 mm 0 — 13–24 mm 0.6 0.1–2.0 ⁎ ≥25 mm 1.3 0.1–5.3 ⁎ Anterior communicating or anterior cerebral artery/middle cerebral artery/internal carotid artery aneurysms &lt;7 mm 0.3 0.1–0.6 ⁎ 7–12 mm 0.5 0.3–0.9 ⁎ 13–24 mm 3.1 2.1–4.4 ⁎ ≥25 mm 9.7 6.9–13.3 ⁎ Posterior circulation/posterior communicating artery aneurysms &lt;7 mm 0.7 0.3–1.4 ⁎ 7–12 mm 3.1 2.0–4.5 ⁎ 13–24 mm 4.0 2.4–6.2 ⁎ ≥25 mm 12.9 8.5–18.7 ⁎ Relative risks of mortality No disability after SAH Cohort study ( ) Age, 4–39 6.3 4.4–9.0 Age, 40–54 2.4 1.8–3.2 Age, 55+ 1.3 1.0–1.7 Disability after SAH Cohort study ( ) Age, 4–44 8.7 7.1–10.6 Age, 45–54 5.4 4.5–6.5 Age, 55+ 3.4 2.9–3.8</p><p>ISUIA, International Study of Unruptured Intracranial Aneurysms; SAH, subarachnoid hemorrhage.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="outcome-measures"><span class="mr-2">Outcome Measures</span><a href="#outcome-measures" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="analyses-performed"><span class="mr-2">Analyses Performed</span><a href="#analyses-performed" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Effectiveness, Cost, and Cost-Effectiveness Compared with No Treatment for 50-Year-Old Patients with a History of Subarachnoid Hemorrhage from a Previous Aneurysm</p><p>QALYs Cost, $ Incremental Cost per QALY, $ Average Incremental (95% CI) Average Incremental (95% CI) A) Cavernous carotid artery aneurysm, &lt;7 mm No treatment 18.2 0 Surgery 16.7 −1.6 (−2.1, −1.1) 45,800 45,800 (34,200, 59,900) Ineffective Endovascular treatment 17.3 −1.0 (−1.7, −0.5) 33,200 33,200 (24,000, 44,800) Ineffective B) Cavernous carotid artery aneurysm, 7−12 mm No treatment 18.2 0 Surgery 16.6 −1.6 (−2.1, −1.1) 45,500 45,500 (34,100, 59,300) Ineffective Endovascular treatment 17.2 −1.0 (−1.7, −0.5) 33,200 33,200 (23,900, 44,900) Ineffective C) Cavernous carotid artery aneurysm, 13−24 mm No treatment 16.5 8,800 Surgery 14.9 −1.6 (−3.2, 0.6) 61,300 52,400 (29,000, 73,400) Ineffective Endovascular treatment 16.7 0.2 (−1.3, 1.7) 38,200 29,300 (14,700, 43,700) 142,100 D) Cavernous carotid artery aneurysm, ≥25 mm No treatment 15.7 16,500 Surgery 14.0 −1.8 (−4.5, 2.3) 70,000 53,600 (12,400, 84,700) Ineffective Endovascular treatment 15.6 −0.07 (−2.2, 2.2) 46,800 30,300 (7,600, 50,800) Ineffective E) Anterior circulation aneurysm, &lt;7 mm No treatment 16.8 5,000 Surgery 16.7 −0.2 (−1.3, 0.9) 45,600 40,700 (28,500, 55,100) Ineffective Endovascular treatment 17.0 0.2 (−0.9, 1.3) 35,100 30,100 (20,400, 41,800) 146,300 F) Anterior circulation aneurysm, 7−12 mm No treatment 16.5 8,400 Surgery 16.6 0.1 (−0.9, 1.3) 45,500 37,100 (24,600, 51,300) 267,300 Endovascular treatment 16.9 0.4 (−0.7, 1.5) 36,400 27,900 (18,100, 40,000) 69,200 G) Anterior circulation aneurysm, 13−24 mm No treatment 13.5 38,700 Surgery 14.9 1.4 (−0.3, 3.2) 61,400 22,700 (3,300, 42,900) 16,400 Endovascular treatment 15.3 1.8 (0.5, 3.0) 51,700 13,000 (−100, 26,800) 7,400 H) Anterior circulation aneurysm, ≥25 mm No treatment 9.8 73,000 Surgery 13.9 4.1 (1.6, 6.7) 70,200 −2,900 (−31,100, 24,600) −700 Endovascular treatment 12.1 2.3 (0.7, 3.9) 79,300 6,300 (−9,800, 22,900) 2,700 I) Posterior circulation aneurysm, &lt;7 mm No treatment 16.3 10,800 Surgery 16.5 0.2 (−1.4, 1.8) 46,700 35,900 (18,900, 54,500) 146,900 Endovascular treatment 16.6 0.4 (−1.4, 1.7) 38,800 27,900 (15,100, 44,300) 78,100 J) Posterior circulation aneurysm, 7−12 mm No treatment 13.5 38,600 Surgery 16.5 3.0 (1.1, 4.9) 46,600 8,100 (−13,200, 28,900) 2,700 Endovascular treatment 15.3 1.8 (0.1, 3.2) 51,400 12,800 (−1,100, 28,200) 7,200 K) Posterior circulation aneurysm, 13−24 mm No treatment 12.8 45,600 Surgery 12.5 −0.3 (−3.2, 2.6) 83,100 35,500 (7,000, 71,500) Ineffective Endovascular treatment 13.0 0.2 (−2.4, 2.2) 69,400 23,800 (5,000, 47,400) 136,400 L) Posterior circulation aneurysm, ≥25 mm No treatment 9.0 80,500 Surgery — — — — — Endovascular treatment 8.7 −0.3 (−2.5, 1.8) 103,800 23,300 (3,900, 45,900) Ineffective</p><p>CI, confidence interval; QALY, quality-adjusted life-year.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Effectiveness, Cost, and Cost-Effectiveness Compared with No Treatment for 40-Year-Old Patients with a History of Subarachnoid Hemorrhage from a Previous Aneurysm</p><p>QALYs Cost, $ Incremental Cost per QALY, $ Average Incremental (95% CI) Average Incremental (95% CI) A) Cavernous carotid artery aneurysm, &lt;7 mm No treatment 21.2 0 Surgery 20.3 −0.9 (−1.3, −0.6) 39,800 39,800 (29,300, 53,100) Ineffective Endovascular treatment 20.0 −1.3 (−2.5, −0.5) 35,700 35,700 (25,000, 50,300) Ineffective B) Cavernous carotid artery aneurysm, 7−12 mm No treatment 21.2 0 Surgery 20.3 −0.9 (−1.3, −0.6) 39,700 39,700 (29,200, 52,500) Ineffective Endovascular treatment 19.9 −1.3 (−2.5, −0.5) 35,600 35,600 (24,800, 50,300) Ineffective C) Cavernous carotid artery aneurysm, 13−24 mm No treatment 19.0 11,100 Surgery 20.5 1.5 (−0.2, 4.1) 37,900 26,700 (1,900, 44,900) 17,900 Endovascular treatment 19.9 0.9 (−1.1, 2.7) 36,600 25,500 (8,900, 43,400) 29,100 D) Cavernous carotid artery aneurysm, ≥25 mm No treatment 18.0 20,400 Surgery 17.7 −0.4 (−4.6, 5.2) 64,700 44,300 (−7,700, 86,800) Ineffective Endovascular treatment 17.6 −0.4 (− 5.0, 2.9) 54,900 34,400 (4,500, 72,800) Ineffective E) Anterior circulation aneurysm, &lt;7 mm No treatment 19.5 6,200 Surgery 20.3 0.8 (−0.4, 2.0) 39,800 33,500 (21,800, 47,000) 42,300 Endovascular treatment 19.7 0.2 (−1.4, 1.5) 37,900 31,700 (20,400, 45,800) 181,000 F) Anterior circulation aneurysm, 7−12 mm No treatment 19.1 10,700 Surgery 20.3 1.3 (0.0, 2.6) 39,800 29,100 (15,800, 43,300) 23,100 Endovascular treatment 19.5 0.5 (−1.1, 1.8) 39,600 28,900 (17,500, 43,500) 63,300 G) Anterior circulation aneurysm, 13−24 mm No treatment 15.2 46,700 Surgery 20.5 5.3 (3.4, 7.4) 37,800 −8,900 (−31,200, 11,500) −1,700 Endovascular treatment 18.0 2.8 (1.0, 4.3) 53,800 7,100 (−8,000, 23,600) 2,600 H) Anterior circulation aneurysm, ≥25 mm No treatment 10.9 84,100 Surgery 17.7 6.8 (2.9, 10.2) 64,600 −19,500 (−55,300, 19,200) −2,900 Endovascular treatment 13.3 2.4 (−0.9, 4.6) 91,800 7,700 (−12,800, 33,900) 3,300 I) Posterior circulation aneurysm, &lt;7 mm No treatment 18.8 13,500 Surgery 19.4 0.6 (−1.4, 2.6) 48,400 34,900 (16,200, 56,300) 55,600 Endovascular treatment 18.8 0.004 (−2.9, 1.9) 45,600 32,100 (15,900, 57,500) 8,750,500 J) Posterior circulation aneurysm, 7−12 mm No treatment 15.2 46,500 Surgery 19.4 4.2 (1.9, 6.5) 48,300 1,900 (−22,100, 25,900) 400 Endovascular treatment 17.1 1.8 (−0.8, 3.7) 60,600 14,200 (−3,300, 36,100) 7,700 K) Posterior circulation aneurysm, 13−24 mm No treatment 14.3 54,800 Surgery 16.7 2.4 (−2.0, 6.2) 73,400 18,700 (−18,700, 64,300) 7,700 Endovascular treatment 15.7 1.3 (−4.4, 4.2) 72,000 17,200 (−7,500, 63,200) 12,900 L) Posterior circulation aneurysm, ≥25 mm No treatment 10.0 92,000 Surgery 14.4 4.4 (0.9, 7.9) 95,500 3,500 (−33,000, 41,800) 800 Endovascular treatment — — — — —</p><p>CI, confidence interval; QALY, quality-adjusted life-year.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Summary of Results of Probabilistic Sensitivity Analyses</p><p>Age, 50 y Age, 40 y Surgery Endovascular Treatment Surgery Endovascular Treatment Cavernous carotid artery aneurysm A) &lt;7 mm — — — — B) 7−12 mm — — — — C) 13−24 mm — — O O D) ≥25 mm — — — — Anterior circulation aneurysm E) &lt;7 mm — — O — F) 7−12 mm — O O O G) 13−24 mm O O O O H) ≥25 mm O O O O Posterior circulation aneurysm I) &lt;7 mm — O O — J) 7−12 mm O O O O K) 13−24 mm — — O O L) ≥25 mm — — O —</p><p>O indicates that the strategy was cost-effective (incremental cost-effectiveness ratio &lt;$100,000 per quality-adjusted life-year) compared with no treatment.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion-1"><span class="mr-2">Conclusion</span><a href="#conclusion-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Rinkel G.J.E., Djibuti M., Algra A., van Gijn J.: Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke 1998; 29: pp. 251-256.</p><li><p>2. Donnan G.A., Davis S.M.: Patients with small, asymptomatic, unruptured intracranial aneurysms and no history of subarachnoid hemorrhage should be treated conservatively. Stroke 2005; 36: pp. 407.</p><li><p>3. Wiebers D.O.: Patients with small, asymptomatic, unruptured intracranial aneurysms and no history of subarachnoid hemorrhage should generally be treated conservatively: For. Stroke 2005; 36: pp. 408-409.</p><li><p>4. Weir B.: Patients with small, asymptomatic, unruptured intracranial aneurysms and no history of subarachnoid hemorrhage should be treated conservatively: Against. Stroke 2005; 36: pp. 410-411.</p><li><p>5. International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: pp. 103-110.</p><li><p>6. Ronkainen A., Niskanen M., Rinne J., Koivisto T., Hernesniemi J., Vapalahti M.: Evidence for excess long-term mortality after treated subarachnoid hemorrhage. Stroke 2001; 32: pp. 2850-2853.</p><li><p>7. Aoki N., Beck J.R., Kitahare T., et. al.: Reanalysis of unruptured intracranial aneurysm management: Effect of a new international study on the threshold probabilities. Med Decis Making 2001; 21: pp. 87-96.</p><li><p>8. Johnston S.C., Gress D.R., Kahn J.G.: Which unruptured cerebral aneurysms should be treated?. Neurology 1999; 52: pp. 1806-1815.</p><li><p>9. Aoki N., Kitahara T., Fukui T., et. al.: Management of unruptured intracranial aneurysm in Japan: A Markovian decision analysis with utility measurements based on the Glasgow Outcome Scale. Med Decis Making 1998; 18: pp. 357-364.</p><li><p>10. King J.T., Glick H.A., Mason T.J., Flamm E.S.: Elective surgery for asymptomatic, unruptured, intracranial aneurysms: A cost-effectiveness analysis. J Neurosurg 1995; 83: pp. 403-412.</p><li><p>11. Leblanc R., Worsley K.J.: Surgery of unruptured, asymptomatic aneurysms: A decision analysis. Can J Neurol Sci 1995; 22: pp. 30-35.</p><li><p>12. van Crevel H., Habbema J.D.F., Braakman R.: Decision analysis of the management of incidental intracranial saccular aneurysms. Neurology 1986; 36: pp. 1335-1339.</p><li><p>13. Takao H., Nojo T.: Treatment of unruptured intracranial aneurysms: Decision and cost-effectiveness analysis. Radiology 2007; 244: pp. 755-766.</p><li><p>14. Hunink M.G., Glasziou P.P., Siegel J.E., et. al.: Decision Making in Halth and Medicine: Integrating Evidence and Values.2001.Cambridge University PressCambridge, UK</p><li><p>15. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C.: Cost-effectiveness in Health and Medicine.1996.Oxford University PressNew York</p><li><p>16. Drummond M.F., Sculpher M.J., Torrance G.W., O’Brien B.J., Stoddart G.L.: Methods for the Economic Evaluation of Health Care Programmes.2005.Oxford University PressNew York</p><li><p>17. Doubilet P., Begg C.B., Weinstein M.C., Braun P., McNeil B.J.: Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach. Med Decis Making 1985; 5: pp. 157-177.</p><li><p>18. Vindlacheruvu R.R., Mendelow A.D., Mitchell P.: Risk-benefit analysis of the treatment of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2005; 76: pp. 234-239.</p><li><p>19. Mitchell P., Gholkar A., Vindlacheruvu R.R., Mendelow A.D.: Unruptured intracranial aneurysms: Benign curiosity or ticking bomb?. Lancet Neurol 2004; 3: pp. 85-92.</p><li><p>20. U.S. Department of Labor, Bureau of Labor Statistics: http://www.bls.gov Accessed March 6, 2006.</p><li><p>21. Laupacis A., Feeny D., Detsky A.S., Tugwell P.X.: How attractive does a new technology have to be to warrant adoption and utilization?. CMAJ 1992; 146: pp. 473-481.</p><li><p>22. International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: Risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339: pp. 1725-1733.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-15/'>Volume 15</a>, <a href='/categories/issue-9/'>Issue 9</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Cost-effectiveness%20of%20Treatment%20of%20Unruptured%20Intracranial%20Aneurysms%20in%20Patients%20with%20a%20History%20of%20Subarachnoid%20Hemorrhage%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Cost-effectiveness%20of%20Treatment%20of%20Unruptured%20Intracranial%20Aneurysms%20in%20Patients%20with%20a%20History%20of%20Subarachnoid%20Hemorrhage%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcost-effectiveness-of-treatment-of-unruptured-intracranial-aneurysms-in-patients-with-a-history-of-s%2F&text=Cost-effectiveness%20of%20Treatment%20of%20Unruptured%20Intracranial%20Aneurysms%20in%20Patients%20with%20a%20History%20of%20Subarachnoid%20Hemorrhage%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/3-t-mri-with-phased-array-coil-in-local-staging-of-prostatic-cancer/"><div class="card-body"> <em class="small" data-ts="1220202000" data-df="ll" > Aug 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>3-T MRI with Phased-array Coil in Local Staging of Prostatic Cancer</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate the diagnostic accuracy of a 3-T magnetic resonance imaging (MRI) system with a phased-array coil (3T MRI) in the local staging of prostatic cancer. Materials...</p></div></div></a></div><div class="card"> <a href="/posts/a-comparison-of-world-wide-web-resources-for-identifying-medical-information/"><div class="card-body"> <em class="small" data-ts="1220202000" data-df="ll" > Aug 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Comparison of World Wide Web Resources for Identifying Medical Information</h3><div class="text-muted small"><p> Rationale and Objectives To compare the utility of a search engine, Google, with other medical and non-medical, web-based resources for identifying specific medical information. Materials and Met...</p></div></div></a></div><div class="card"> <a href="/posts/abstracts-of-funded-national-institutes-of-health-grants/"><div class="card-body"> <em class="small" data-ts="1220202000" data-df="ll" > Aug 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abstracts of Funded National Institutes of Health Grants</h3><div class="text-muted small"><p> The following abstracts of diagnostic radiology research and training grants funded by the National Institutes of Health (NIH) were awarded to principal investigators (PIs) whose primary appointmen...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/automatic-segmentation-of-lung-parenchyma-in-the-presence-of-diseases-based-on-curvature-of-ribs/" class="btn btn-outline-primary" prompt="Older"><p>Automatic Segmentation of Lung Parenchyma in the Presence of Diseases Based on Curvature of Ribs</p></a> <a href="/posts/establishment-and-results-of-a-magnetic-resonance-quality-assurance-program-for-the-pediatric-brain/" class="btn btn-outline-primary" prompt="Newer"><p>Establishment and Results of a Magnetic Resonance Quality Assurance Program for the Pediatric Brain Tumor Consortium</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
